Agate Medical Investments

Total investments

19

Average round size

17M

Portfolio companies

14

Rounds per year

1.27

Lead investments

2

Follow on index

0.26

Exits

5

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInformation TechnologyInformation ServicesArtificial IntelligenceHealth CareBig DataMedical DeviceMedicalTherapeuticsConsulting

Summary

Agate Medical Investments is the famous VC, which was founded in 2007. The main department of described VC is located in the Tel Aviv. The company was established in Asia in Israel.

The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Agate Medical Investments performs on 12 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2019. The top activity for fund was in 2015. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations.

The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Ornim Medical, Brainsgate, Navotek Medical Among the most successful fund investment fields, there are Machine Learning, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel.

We also calculated 1 valuable employee in our database.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Agate Medical Investments, startups are often financed by Viola Partners, Pitango Venture Capital, XT Investments. The meaningful sponsors for the fund in investment in the same round are Pitango Venture Capital, XT Investments, Viola Partners. In the next rounds fund is usually obtained by XT Investments, Viola Partners, Triventures.

Show more

Investments analytics

Analytics

Total investments
19
Lead investments
2
Exits
5
Rounds per year
1.27
Follow on index
0.26
Investments by industry
  • Health Care (19)
  • Medical Device (12)
  • Medical (11)
  • Biotechnology (9)
  • Therapeutics (4)
  • Show 15 more
Investments by region
  • United States (5)
  • Israel (11)
  • Switzerland (1)
  • Czech Republic (1)
  • South Korea (1)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
16M
Group Appearance index
0.79
Avg. company exit year
24
Avg. multiplicator
0.04

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CLEW Medical 01 Feb 2017 Information Technology, Information Services, Health Care, Big Data Early Stage Venture 8M North District, Israel, Israel
MST Medical Surgery Technologies 01 Jul 2015 Analytics, Artificial Intelligence, Machine Learning, Health Care, Robotics, Medical Device, Medical Late Stage Venture 12M North District, Israel, Israel

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.